References
- Sadeghian M, Asadi M, Rahmani S, Sadeghi N, Hosseini SA, Zare Javid A. Lycopene does not affect prostate-specific antigen in men with non-metastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials. Nutr Cancer. 2020;1–12. doi:https://doi.org/10.1080/01635581.2020.1862254
- Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001;10(8):861–8.
- Kucuk O, Sarkar FH, Sakr W, Khachik F, Djuric Z, Banerjee M, Pollak MN, Bertram JS, Wood DP. Lycopene in the treatment of prostate cancer. Pure Appl Chem. 2002;74(8):1443–50. doi:https://doi.org/10.1351/pac200274081443
- Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, et al. Tomato-based randomized controlled trial in prostate cancer patients: effect on PSA. Clin Nutr. 2017;36(3):672–9. doi:https://doi.org/10.1016/j.clnu.2016.06.014
- Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, Patrick AL. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer. 2007;57(2):130–7. doi:https://doi.org/10.1080/01635580701274046
- Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Krischer JP. Results of a randomized clinical trial of the action of several doses of lycopene in localized prostate cancer: administration prior to radical prostatectomy. Clin Med Urol. 2008;1:1–14.
- Gann PH, Deaton RJ, Rueter EE, van Breemen RB, Nonn L, Macias V, Han M, Ananthanarayanan V. A phase II randomized trial of lycopene-rich tomato extract among men with high-grade prostatic intraepithelial neoplasia. Nutr Cancer. 2015;67(7):1104–12. doi:https://doi.org/10.1080/01635581.2015.1075560
- Cochrane handbook for systematic reviews of interventions. Available from: https://handbook-5-1.cochrane.org/chapter_7/7_2_2_identifying_multiple_reports_from_the_same_study.htm.
- Cochrane handbook for systematic reviews of interventions 2011. Available from: https://handbook-5-1.cochrane.org/chapter_16/16_5_4_how_to_include_multiple_groups_from_one_study.htm.
- Lane JA, Er V, Avery KNL, Horwood J, Cantwell M, Caro GP, Crozier A, Smith GD, Donovan JL, Down L, et al. ProDiet: a phase II randomized placebo-controlled trial of green tea Catechins and lycopene in men at increased risk of prostate cancer. Cancer Prev Res. 2018;11(11):687–96. doi:https://doi.org/10.1158/1940-6207.CAPR-18-0147